Comparison
TB-500 vs thymosin beta-4: fragment or full protein?
The two names are often used as if they were interchangeable. They are not: one is a 43-residue protein and the other, as usually described, is a 7-residue piece of it. Here is what the papers say about each, and how to tell which one is in a vial.
At a glance
| Thymosin beta-4 | TB-500 (as usually described) | |
|---|---|---|
| What it is | A naturally occurring protein, the major actin-sequestering molecule in eukaryotic cells | A supplier name for a synthetic peptide related to thymosin beta-4 |
| Length | 43 amino acids | 7 amino acids |
| Sequence | Ac-SDKPDMAEIEKFDKSKLKKTETQEKNPLPSKETIEQEKQAGES (N-terminally acetylated) | Ac-LKKTETQ (residues 17 to 23) |
| Formula (PubChem) | C212H350N56O78S, about 4963 g/mol | C38H68N10O14, about 889 g/mol |
| Monoisotopic mass from the formula | 4960.49 Da | 888.49 Da; [M+H]+ 889.50 |
| Contains the actin-binding motif | Yes | Yes (this is the motif) |
| Contains Ac-SDKP (residues 1 to 4) | Yes | No |
Where the fragment comes from
Thymosin beta-4 is a 43-residue protein that sequesters monomeric G-actin in a 1:1 ratio (Hannappel and Wartenberg, 1993; Goldstein et al., 2005; Hannappel, 2007). Sosne et al. (2010) review short sequences within the protein that have been linked to particular activities in cell and tissue models: the N-terminal Ac-SDKP, a 15-residue N-terminal site that includes it, and a short sequence containing LKKTETQ, the central actin-binding region, which they associate with cell migration, angiogenesis and wound-healing models. The numbering on this page follows the sequence above: Leu17 to Gln23 is LKKTETQ.
What a vial labelled TB-500 contains
TB-500 is not a standardised chemical name. Esposito et al. (2012) describe finding the N-terminally acetylated 17-23 fragment, Ac-LKKTETQ, in a product named TB-500 by HPLC with high-resolution mass spectrometry, and synthesising it by solid-phase peptide synthesis as a reference. That is the source of the usual description of TB-500 as a fragment. A vial sold under the name may therefore hold either molecule, which is why identity should be verified by mass, not by name. For a fragment of about 889 g/mol and the full protein at about 4963 g/mol the two are unmistakable by mass spectrometry: expect [M+H]+ near 889.50 for the fragment, and a charge-state series from the 4+ ion upward (about 1241.9, 993.7, 828.3) for the full protein.
What the fragment studies show
- Actin sequestering needs more than the central motif. In a DNase I inhibition assay, thymosin beta-4 sequestered G-actin 1:1, while fragments 13-43 and 24-43 did not inhibit polymerisation. The authors conclude that structural features before position 13 are needed for that function (Hannappel and Wartenberg, 1993).
- Metabolism of the fragment. Rahaman et al. (2024) quantified Ac-LKKTETQ and its metabolites in vitro and in rats by UHPLC-Orbitrap MS/MS. They report Ac-LK as the main early metabolite and Ac-LKK as a longer-lived one detected up to 72 hours, no cytotoxicity of the parent or metabolites, and, among the compounds tested in a fibroblast scratch assay, a significant effect only for the metabolite Ac-LKKTE. They suggest that wound-healing activity previously attributed to TB-500 may be due to a metabolite rather than the parent form.
Together these papers say that results obtained with full-length thymosin beta-4 cannot be assumed for the fragment, or the other way round. A study should state which molecule, its sequence and its supplier's mass-spectrometry data.
How to check which one you have
- Read the mass-spectrometry section of the batch COA and compare the reported m/z or deconvoluted mass with the table above. This guide shows how to compute the expected ions.
- Check that the COA gives the sequence or the name of the molecule, not only "TB-500".
- For the fragment, confirm the N-terminal acetyl group: the acetylated form is 42.01 Da heavier than the free peptide (Ac-LKKTETQ 888.49 Da vs LKKTETQ 846.48 Da).
Catalog and related pages
- TB-500 research peptide: sizes, prices, identity data
- BPC-157 vs TB-500
- How to read a peptide Certificate of Analysis
- All tissue-repair peptides
Related
References
- Hannappel E, Wartenberg F (1993). Actin-sequestering ability of thymosin beta 4, thymosin beta 4 fragments, and thymosin beta 4-like peptides as assessed by the DNase I inhibition assay. Biol Chem Hoppe Seyler 374:117-22. PubMed 8471179 · DOI
- Sosne G, Qiu P, Goldstein AL, et al. (2010). Biological activities of thymosin beta4 defined by active sites in short peptide sequences. FASEB J 24:2144-51. PubMed 20179146 · DOI
- Esposito S, Deventer K, Goeman J, et al. (2012). Synthesis and characterization of the N-terminal acetylated 17-23 fragment of thymosin beta 4 identified in TB-500, a product suspected to possess doping potential. Drug Test Anal 4:733-8. PubMed 22962027 · DOI
- Rahaman KA, Muresan AR, Min H, et al. (2024). Simultaneous quantification of TB-500 and its metabolites in in-vitro experiments and rats by UHPLC-Q-Exactive orbitrap MS/MS and their screening by wound healing activities in-vitro. J Chromatogr B Analyt Technol Biomed Life Sci 1235:124033. PubMed 38382158 · DOI
- Goldstein AL, Hannappel E, Kleinman HK (2005). Thymosin beta4: actin-sequestering protein moonlights to repair injured tissues. Trends Mol Med 11:421-9. PubMed 16099219 · DOI
- Hannappel E (2007). beta-Thymosins. Ann N Y Acad Sci 1112:21-37. PubMed 17468232 · DOI
- Sosne G, Qiu P, Kurpakus-Wheater M (2007). Thymosin beta 4: A novel corneal wound healing and anti-inflammatory agent. Clin Ophthalmol 1:201-7. PubMed 19668473
Frequently asked questions
Is TB-500 the same as thymosin beta-4?
No. Thymosin beta-4 is a 43-amino-acid protein (about 4963 g/mol). TB-500 is a supplier name that is commonly used for the 7-residue fragment Ac-LKKTETQ (about 889 g/mol), which corresponds to residues 17 to 23 of thymosin beta-4. Because the name is not standardised, the mass on a batch COA is what settles which one a vial contains.
Has Ac-LKKTETQ been found in products sold as TB-500?
Yes. Esposito et al. (2012) report detecting and identifying Ac-LKKTETQ in a TB-500 product using HPLC and high-resolution mass spectrometry, and synthesised it by solid-phase peptide synthesis to confirm the identification.
Which part of thymosin beta-4 binds actin?
The central region around residues 17 to 23 (LKKTETQ) is described as the actin-binding domain. Hannappel and Wartenberg (1993) also found that fragments 13-43 and 24-43 did not inhibit actin polymerisation, so sequence before position 13 matters for the full actin-sequestering function.